Since 2010, Frank Buchholz is Professor of Medical Systems Biology and Head of Translational Research at the University Cancer Center (UCC) of TU Dresden. He is also Dean of Research at the Medical Faculty Carl Gustav Carus. Already during his PhD he did pioneering work on the implementation and improvement of sequence-specific recombinases in the field of genome engineering. Frank perfected this approach as a group leader at the Max Planck-Institute CBG Dresden and developed a designer-recombinase that can eliminate HIV from infected cells. This completely novel antiretroviral approach has been widely recognized as a breakthrough in enzyme technology, offering a promising new avenue for treating patients with HIV infections. Further developments of the technology has led to the establishment of two start-up companies.
Login or Register
You need to be logged in to use this feature.
TU Dresden
Frank Buchholz
Content by this speaker
Explore more content of Falling Walls
Events with Frank Buchholz
SPRIND Sciencepreneurship Symposium
Further Activities to have a look at